Gilead Sciences, Inc. (GILD)

Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of $168.64 billion as of April 20, 2026. Its market cap has increased by 20.49% in one year.

• Market Cap: 168.64B
• Enterprise Value: 181.60B
• 1-Year Change: 20.49%
• Ranking: #85
• Category: Large-Cap
• Stock Price: $135.87

Market Cap Chart

Since December 1, 1998, Gilead Sciences's market cap has increased from $973.10M to $168.64B, an increase of 17,230.68%. That is a compound annual growth rate of 20.70%.

Market Cap History

Date	Market Cap	% Change
Apr 20, 2026	168.67B	10.76%
Dec 31, 2025	152.28B	32.28%
Dec 31, 2024	115.12B	14.04%
Dec 29, 2023	100.94B	-6.25%
Dec 30, 2022	107.68B	18.22%
Dec 31, 2021	91.08B	24.72%
Dec 31, 2020	73.03B	-11.17%
Dec 31, 2019	82.21B	1.60%
Dec 31, 2018	80.92B	-13.53%
Dec 29, 2017	93.58B	-0.81%
Dec 30, 2016	94.34B	-35.31%
Dec 31, 2015	145.83B	2.55%
Dec 31, 2014	142.21B	23.49%
Dec 31, 2013	115.15B	106.93%
Dec 31, 2012	55.65B	81.01%
Dec 30, 2011	30.74B	4.49%
Dec 31, 2010	29.42B	-24.44%
Dec 31, 2009	38.94B	-16.37%
Dec 31, 2008	46.56B	8.73%
Dec 31, 2007	42.82B	43.43%
Dec 29, 2006	29.86B	24.03%
Dec 30, 2005	24.07B	58.92%
Dec 31, 2004	15.15B	28.36%
Dec 31, 2003	11.80B	76.49%
Dec 31, 2002	6.69B	6.07%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Johnson & Johnson	555.64B
AbbVie	360.31B
AstraZeneca	313.96B
Novartis AG	290.03B
Merck & Co.	289.22B
Amgen	188.98B
Novo Nordisk	180.44B
Pfizer	156.54B